DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Emend (Aprepitant) - Septic Shock - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Septic Shock (9)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Emend (Aprepitant) where reactions include septic shock. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Emend side effects in

Reported by a physician from France on 2012-08-01

Patient:

Reactions: Renal Failure, Lung Disorder, Toxic Encephalopathy, Drug Interaction, Pancytopenia, Septic Shock

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Emend

Other drugs received by patient possibly interacting with the suspect drug:
Cyclophosphamide
    Dosage: unk
    Indication: Sarcoma
    Start date: 2012-03-22

Cyclophosphamide
    Dosage: unk
    Start date: 2012-04-23

Cyclophosphamide
    Dosage: unk

Other drugs received by patient: Calciparine; Granocyte; Zofran



Possible Emend side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-29

Patient: 68 year old female

Reactions: Intestinal Ischaemia, Dermatitis Bullous, Gastrointestinal Necrosis, Aplasia, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Vancomycin
    Start date: 2012-01-05

Zyvox
    Start date: 2011-12-30

Tazobactam
    Start date: 2011-12-28
    End date: 2012-01-04

Hydrea
    Start date: 2011-12-26
    End date: 2011-12-28

Idarubicin HCL
    Indication: Acute Leukaemia
    Start date: 2011-12-28
    End date: 2012-01-03

Valacyclovir Hydrochloride
    Start date: 2011-12-28

Amiodarone HCL
    Start date: 2011-12-30

Emend
    Administration route: Oral
    Start date: 2011-12-29

Levofloxacin
    Start date: 2011-12-29

Fasturtec
    Start date: 2011-12-28

Cytarabine
    Indication: Acute Leukaemia
    Start date: 2011-12-28
    End date: 2012-01-03

Other drugs received by patient: Metoclopramide; Noxafil; Zofran; Xyzal



Possible Emend side effects in female

Reported by a physician from France on 2012-03-22

Patient: female

Reactions: Intestinal Ischaemia, Hypotension, Tachycardia, Skin Disorder, Gastrointestinal Necrosis, Lactic Acidosis, Aplasia, Multi-Organ Failure, Dehydration, Hepatocellular Injury, Dermatitis Bullous, Septic Shock, Melaena, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Zyvox
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-30

Valacyclovir Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-28

Levofloxacin
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-29

Vancomycin
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-05

Amiodarone Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-30

Hydrea
    Indication: Acute Leukaemia
    Start date: 2011-12-26
    End date: 2011-12-28

Idarubicin HCL
    Indication: Acute Leukaemia
    Start date: 2011-12-28

Rasburicase
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-28

Piperacillin and Tazobactam
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-28
    End date: 2012-01-04

Cytarabine
    Indication: Acute Leukaemia
    Start date: 2011-12-28
    End date: 2012-01-03

Emend
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-29

Other drugs received by patient: Metoclopramide; Noxafil; Zofran



Possible Emend side effects in 68 year old female

Reported by a consumer/non-health professional from France on 2012-03-22

Patient: 68 year old female

Reactions: Intestinal Ischaemia, Bone Marrow Failure, Dermatitis Bullous, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Idarubicin HCL
    Indication: Acute Leukaemia
    Start date: 2011-12-28

Amiodarone Hydrochloride
    Start date: 2011-12-30

Piperacillin and Tazobactam
    Start date: 2011-12-28
    End date: 2012-01-04

Levofloxacin
    Start date: 2011-12-29

Fasturtec
    Start date: 2011-12-28

Emend
    Start date: 2011-12-29

Zyvox
    Start date: 2011-12-30

Hydrea
    Start date: 2011-12-26
    End date: 2011-12-28

Valacyclovir Hydrochloride
    Start date: 2011-12-28

Cytarabine
    Indication: Acute Leukaemia
    Start date: 2011-12-28
    End date: 2012-01-03

Vancomycin
    Start date: 2012-01-05



Possible Emend side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-21

Patient: 68 year old female

Reactions: Intestinal Ischaemia, Dermatitis Bullous, Aplasia, Septic Shock, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Zyvox
    Dosage: unk
    Start date: 2011-12-30

Piperacillin and Tazobactam
    Dosage: unk
    Indication: Antibiotic Therapy
    Start date: 2011-12-28
    End date: 2012-01-04

Idarubicin HCL
    Dosage: unk
    Indication: Acute Leukaemia
    Start date: 2011-12-28

Emend
    Dosage: unk
    Start date: 2011-12-29

Amiodarone HCL
    Dosage: unk
    Start date: 2011-12-30

Cytarabine
    Dosage: 352 mg, unk
    Indication: Acute Leukaemia
    Start date: 2011-12-28
    End date: 2012-01-03

Hydrea
    Dosage: unk
    Start date: 2011-12-26
    End date: 2011-12-28

Levofloxacin
    Dosage: unk
    Start date: 2011-12-29

Vancomycin HCL
    Dosage: unk
    Indication: Antibiotic Therapy
    Start date: 2012-01-05

Valacyclovir Hydrochloride
    Dosage: unk
    Start date: 2011-12-28

Fasturtec
    Dosage: unk
    Start date: 2011-12-28

Other drugs received by patient: Metoclopramide; Zofran; Posaconazole



Possible Emend side effects in 68 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-20

Patient: 68 year old female

Reactions: Intestinal Ischaemia, Bone Marrow Failure, Gastrointestinal Necrosis, Septic Shock, Toxic Skin Eruption, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Fasturtec
    Start date: 2011-12-28

Hydrea
    Start date: 2011-12-26
    End date: 2011-12-28

Vancomycin
    Start date: 2012-01-05

Levofloxacin
    Start date: 2011-12-29

Cytarabine
    Start date: 2011-12-28

Emend
    Start date: 2011-12-29

Valaciclovir
    Start date: 2011-12-28

Cytarabine

Piperacillin and Tazobactam
    Start date: 2011-12-28
    End date: 2012-01-04

Amiodarone Hydrochloride
    Start date: 2011-12-30

Idarubicin HCL
    Start date: 2011-12-28

Zyvox
    Start date: 2011-12-30

Other drugs received by patient: Metoclopramide; Zofran; Noxafil



Possible Emend side effects in female

Reported by a physician from France on 2012-02-28

Patient: female

Reactions: Hypovolaemic Shock, Renal Failure, Encephalopathy, Tachypnoea, Urinary Retention, Lactic Acidosis, Septic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ifosfamide
    Dosage: 4160mg per day
    Indication: Endometrial Sarcoma
    Start date: 2011-12-05
    End date: 2011-12-06

Zofran
    Dosage: 8mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Mesna
    Dosage: 1300mg three times per day
    Indication: Endometrial Sarcoma
    Start date: 2011-12-05
    End date: 2011-12-06

Emend
    Dosage: 80mg per day
    Administration route: Oral
    Indication: Endometrial Sarcoma
    Start date: 2011-12-05
    End date: 2011-12-06

Solu-Medrol
    Dosage: 40mg per day
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Other drugs received by patient: Duragesic-100; Lyrica; Oxycodone HCL



Possible Emend side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-28

Patient: 61 year old female

Reactions: Renal Failure, Encephalopathy, Septic Shock

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Solu-Medrol
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Zofran
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Ifosfamide
    Indication: Uterine Cancer
    Start date: 2011-12-05
    End date: 2011-12-06

Uromitexan Baxter
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Emend
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-12-05
    End date: 2011-12-06

Other drugs received by patient: Pregabalin; Duragesic-100; Pregabalin; Oxycodone HCL



Possible Emend side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-02-23

Patient: 61 year old female

Reactions: Urinary Tract Infection, Encephalopathy, Meningitis, Septic Shock, Renal Failure Acute

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Zofran
    Dosage: 8mg/day
    Start date: 2011-12-05
    End date: 2011-12-06

Solu-Medrol
    Dosage: 40mg/day
    Indication: Chemotherapy
    Start date: 2011-12-05
    End date: 2011-12-06

Ifosfamide
    Dosage: 4160mg/day
    Indication: Chemotherapy
    Start date: 2011-12-05
    End date: 2011-12-06

Mesna
    Dosage: 1300 mg, 3x/day
    Indication: Chemotherapy
    Start date: 2011-12-05
    End date: 2011-12-06

Emend
    Dosage: 80mg/day
    Administration route: Oral
    Indication: Chemotherapy
    Start date: 2011-12-05
    End date: 2011-12-06

Other drugs received by patient: Lyrica; Duragesic-100; Oxycodone HCL; Lyrica

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017